Lapatinib Study for Children and Adults With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors
Clinical trial NCT00973739 · COMPLETED
Trial details
- NCT number
- NCT00973739
- Sponsor
- NYU Langone Health
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2012-10-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.